Invited Faculty
  • Masayoshi Harigai
    Tokyo Women's Medical Univ.
  • Masayoshi Harigai, MD, PhD is Professor and Head of Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan. He graduated from National Defense Medical College and received PhD from Keio University in 1991. He served as Professor of Department of Pharmacovigilance at Graduate School of Tokyo Medical and Dental University between 2007 and 2015. After returning to Tokyo Women’s University in 2015 as an Endowed Professor, he was installed in the present position in 2019. Professor Harigai’s main research interests are rheumatoid arthritis and vasculitis syndrome. He is the past principal investigator of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS), clinical trial of tocilizumab for ANCA-associated vasculitis, and 2024 and 2020 Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis. He has been serving as a board member of Japan College of Rheumatology since 2018 and co-convenor of the APLAR vasculitis SIG.
    Research & Clinical Focus

    Pharmacoepidemiology of rheumatoid arthritis

    Development of molecular targeting therapy for ANCA-associated vasculitis

    Genetic epidemiology of ANCA-associated vasculitis

    Infection in patients receiving immunosuppressive treatment

  • Date Time Room Session Title Lecture Title
    May 17 10:30-11:00 Room Room1 International Symposium 2_Optimal Care for Patients with Rheumatic Diseases: Minimizing Treatment-Related Infectious Complications Infectious complications during targeted therapy for rheumatic diseases